PICI
Live / Registered — Registered (as of 10 Dec 2024)
What this means for you
Registered since 10 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98173874
- Registration number
- 7594211
- Mark type
- Design + words
- Filed
- 11 Sept 2023
- Published for opposition
- 08 Oct 2024
- Registered
- 10 Dec 2024
- Attorney of record
- Charles T. J. Weigell
Goods and services
- Class 036 — Insurance and financial services: Capital investment services; providing grants, project-based financial awards, and funding of research awards to scientific and medical research and research projects; charitable foundation services, namely, providing grants, project-based financial awards, and funding of research awards to fund scientific and medical research and research projects
- Class 042 — Scientific and technological services: Scientific and medical research; scientific research in the nature of conducting clinical trials for others; scientific evaluation and analysis of scientific and medical research, research projects and proposals related thereto
Owner
- Parker Institute for Cancer Immunotherapy, San Francisco, CA, US
- Parker Institute for Cancer Immunotherapy, San Francisco, CA, US
- Parker Institute for Cancer Immunotherapy, San Francisco, CA, US
Prosecution history
- 10 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 08 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2024 — PUBLISHED FOR OPPOSITION
- 18 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jul 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jul 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 18 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 May 2024 — NON-FINAL ACTION E-MAILED
- 18 May 2024 — NON-FINAL ACTION WRITTEN
- 06 May 2024 — ASSIGNED TO EXAMINER